These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9440120)

  • 21. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention.
    Yang DS; Serpell LC; Yip CM; McLaurin J; Chrishti MA; Horne P; Boudreau L; Kisilevsky R; Westaway D; Fraser PE
    Amyloid; 2001 Jul; 8 Suppl 1():10-9. PubMed ID: 11676284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics of familial Alzheimer's disease.
    Schellenberg GD
    Arzneimittelforschung; 1995 Mar; 45(3A):418-24. PubMed ID: 7763337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
    Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
    J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Etiology and genetics of Alzheimer disease].
    Myhre A; Tysnes OB
    Tidsskr Nor Laegeforen; 2002 Jan; 122(1):50-3. PubMed ID: 11851296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [beta-amyloid cascade: current status and future directions].
    Iwatsubo T
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1228-30. PubMed ID: 11464463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presenilin-1 is associated with Alzheimer's disease amyloid.
    Wisniewski T; Dowjat WK; Permanne B; Palha J; Kumar A; Gallo G; Frangione B
    Am J Pathol; 1997 Aug; 151(2):601-10. PubMed ID: 9250173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of the molecular mechanism of amyloid formation for the understanding of the pathogenesis of Alzheimer's disease and the development of therapeutic strategies.
    Lansbury PT
    Arzneimittelforschung; 1995 Mar; 45(3A):432-4. PubMed ID: 7763339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced beta-amyloid response in lymphocytes of patients with Alzheimer's disease.
    Bondy B; Hofmann M; Müller-Spahn F; Witzko M; Hock C
    Pharmacopsychiatry; 1995 Jul; 28(4):143-6. PubMed ID: 7491368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine.
    Griffith LS; Mathes M; Schmitz B
    J Neurosci Res; 1995 Jun; 41(2):270-8. PubMed ID: 7650762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A beta deposition inhibitor screen using synthetic amyloid.
    Esler WP; Stimson ER; Ghilardi JR; Felix AM; Lu YA; Vinters HV; Mantyh PW; Maggio JE
    Nat Biotechnol; 1997 Mar; 15(3):258-63. PubMed ID: 9062926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-amyloid protein probe hybridized to chromosome 9 in 3 Alzheimer disease individuals.
    Jenkins EC; Devine-Gage EA; Yao XL; Houck GE; Brown WT; Robakis NK; Wisniewski KE; Silverman WP; Reisberg B; Wisniewski HM
    Prog Clin Biol Res; 1989; 317():269-75. PubMed ID: 2690102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E and amyloidogenesis.
    Frangione B; Castaño EM; Wisniewski T; Ghiso J; Prelli F; Vidal R
    Ciba Found Symp; 1996; 199():132-41; discussion 141-5. PubMed ID: 8915608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid aggregation inhibitors.
    Zagorski MG
    IDrugs; 1998 May; 1(1):17-8. PubMed ID: 18465494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the binding of beta-amyloid protein to antichymotrypsin in Alzheimer plaques mediated by a beta-strand insertion?
    Lukacs CM; Christianson DW
    Proteins; 1996 Aug; 25(4):420-4. PubMed ID: 8865337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giving Alzheimer's the old one-two.
    Wolfe MS; Selkoe DJ
    Cell; 2010 Jul; 142(2):194-6. PubMed ID: 20655461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.